Teva CEO Jeremy Levin

Teva CEO Jeremy Levin

Scott Eells/Bloomberg

Teva Pharmaceutical Industries Ltd. Chief Executive Officer Jeremy Levin, who joined the world’s largest maker of generic drugs in May, presented his growth plan for Teva on Dec. 11 as the company seeks to substitute revenue for its best-selling multiple sclerosis treatment Copaxone amid mounting competition.